Could a simple swab replace invasive tests for uterine cancer?
NCT ID NCT07298707
Summary
This study aims to see if a new molecular test (CISENDO) using a cervical swab sample can accurately detect and monitor pre-cancerous and cancerous endometrial lesions. It will enroll 3,500 women at medium-to-high risk for endometrial cancer. Researchers will compare the test's results to the current standard diagnostic procedure (hysteroscopy) to see if it can reliably identify high-risk conditions and track changes over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.